Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rectal cancer (a type of gland-based cancer located in the lower part of the bowel, below a certain internal boundary called the peritoneal reflection), confirmed through a tissue test
- People whose cancer is classified as Stage III
- People whose tumor is considered removable by surgery with the aim of clearing all cancer
- People who have not previously had chemotherapy or radiation therapy to the pelvic area for any cancer
- People whose cancer has been assessed by a team of specialists (including surgeons, radiologists, and oncologists) using MRI and ultrasound, and confirmed to be at a specific stage (T1–3, N1–2, M0, meaning the cancer has not spread to distant parts of the body)
- People who have given written consent to participate
Who may not be able to join:
- People with a past history of another type of cancer
- People with multiple colorectal cancers at the same time, or a condition called Familial Adenomatous Polyposis (FAP), which is an inherited bowel condition
- People who also have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis
- People whose cancer has come back after previous treatment, or has grown into nearby organs
- People whose cancer is causing a blockage, a tear in the bowel, or serious bleeding that requires emergency surgery
- People whose tumor has grown into specific muscles or structures around the bowel (the external sphincter, levator ani muscle, or adjacent organs)
- People who have taken part in another clinical trial within the past 4 weeks
- People who are rated as being in poor general health according to standard medical scoring tools used by anaesthetists and oncologists (confirm with trial site for exact scoring thresholds)
- People who are pregnant or breastfeeding
- People who have a serious infection before surgery
- People with a psychological disorder
- People with severe organ dysfunction or other medical reasons that make participation unsafe
- People who have had a heart attack within the past six months
- People with severe lung conditions such as emphysema or pulmonary fibrosis
- People excluded based on the treating doctor's clinical judgment
- People where, during surgery, the tumor is found to have grown into other organs, or the tumor location does not match the original assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yanxin Luo, Sixth Affiliated Hospital, Sun Yat-sen University
Phone: 020-38250745
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-year disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.